Literature DB >> 26772608

A calibration hierarchy for risk models was defined: from utopia to empirical data.

Ben Van Calster1, Daan Nieboer2, Yvonne Vergouwe2, Bavo De Cock3, Michael J Pencina4, Ewout W Steyerberg2.   

Abstract

OBJECTIVE: Calibrated risk models are vital for valid decision support. We define four levels of calibration and describe implications for model development and external validation of predictions. STUDY DESIGN AND
SETTING: We present results based on simulated data sets.
RESULTS: A common definition of calibration is "having an event rate of R% among patients with a predicted risk of R%," which we refer to as "moderate calibration." Weaker forms of calibration only require the average predicted risk (mean calibration) or the average prediction effects (weak calibration) to be correct. "Strong calibration" requires that the event rate equals the predicted risk for every covariate pattern. This implies that the model is fully correct for the validation setting. We argue that this is unrealistic: the model type may be incorrect, the linear predictor is only asymptotically unbiased, and all nonlinear and interaction effects should be correctly modeled. In addition, we prove that moderate calibration guarantees nonharmful decision making. Finally, results indicate that a flexible assessment of calibration in small validation data sets is problematic.
CONCLUSION: Strong calibration is desirable for individualized decision support but unrealistic and counter productive by stimulating the development of overly complex models. Model development and external validation should focus on moderate calibration.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calibration; Decision curve analysis; External validation; Loess; Overfitting; Risk prediction models

Mesh:

Year:  2016        PMID: 26772608     DOI: 10.1016/j.jclinepi.2015.12.005

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  149 in total

1.  Application of net reclassification index to non-nested and point-based risk prediction models: a review.

Authors:  Laine E Thomas; Emily C O'Brien; Jonathan P Piccini; Ralph B D'Agostino; Michael J Pencina
Journal:  Eur Heart J       Date:  2019-06-14       Impact factor: 29.983

2.  The number needed to benefit: estimating the value of predictive analytics in healthcare.

Authors:  Vincent X Liu; David W Bates; Jenna Wiens; Nigam H Shah
Journal:  J Am Med Inform Assoc       Date:  2019-12-01       Impact factor: 4.497

3.  A study protocol for the development of a multivariable model predicting 6- and 12-month mortality for people with dementia living in residential aged care facilities (RACFs) in Australia.

Authors:  Ross Bicknell; Wen Kwang Lim; Andrea B Maier; Dina LoGiudice
Journal:  Diagn Progn Res       Date:  2020-10-07

4.  Development and evaluation of a multimodal marker of major depressive disorder.

Authors:  Jie Yang; Mengru Zhang; Hongshik Ahn; Qing Zhang; Tony B Jin; Ien Li; Matthew Nemesure; Nandita Joshi; Haoran Jiang; Jeffrey M Miller; Robert Todd Ogden; Eva Petkova; Matthew S Milak; Mary Elizabeth Sublette; Gregory M Sullivan; Madhukar H Trivedi; Myrna Weissman; Patrick J McGrath; Maurizio Fava; Benji T Kurian; Diego A Pizzagalli; Crystal M Cooper; Melvin McInnis; Maria A Oquendo; Joseph John Mann; Ramin V Parsey; Christine DeLorenzo
Journal:  Hum Brain Mapp       Date:  2018-08-16       Impact factor: 5.038

5.  Predictive Model for High-Risk Coronary Artery Disease.

Authors:  James J Jang; Manjushri Bhapkar; Adrian Coles; Sreekanth Vemulapalli; Christopher B Fordyce; Kerry L Lee; James E Udelson; Udo Hoffmann; Jean-Claude Tardif; W Schuyler Jones; Daniel B Mark; Vincent L Sorrell; Andrey Espinoza; Pamela S Douglas; Manesh R Patel
Journal:  Circ Cardiovasc Imaging       Date:  2019-02       Impact factor: 7.792

6.  Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis.

Authors:  Jejo D Koola; Sam B Ho; Aize Cao; Guanhua Chen; Amy M Perkins; Sharon E Davis; Michael E Matheny
Journal:  Dig Dis Sci       Date:  2019-09-17       Impact factor: 3.199

7.  The External Validity of Prediction Models for the Diagnosis of Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: Insights From the PROMISE Trial.

Authors:  Tessa S S Genders; Adrian Coles; Udo Hoffmann; Manesh R Patel; Daniel B Mark; Kerry L Lee; Ewout W Steyerberg; M G Myriam Hunink; Pamela S Douglas
Journal:  JACC Cardiovasc Imaging       Date:  2017-06-14

8.  Comparison of Prediction Model Performance Updating Protocols: Using a Data-Driven Testing Procedure to Guide Updating.

Authors:  Sharon E Davis; Robert A Greevy; Thomas A Lasko; Colin G Walsh; Michael E Matheny
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

9.  Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems.

Authors:  Matthew J Feinstein; Robin M Nance; Daniel R Drozd; Hongyan Ning; Joseph A Delaney; Susan R Heckbert; Matthew J Budoff; William C Mathews; Mari M Kitahata; Michael S Saag; Joseph J Eron; Richard D Moore; Chad J Achenbach; Donald M Lloyd-Jones; Heidi M Crane
Journal:  JAMA Cardiol       Date:  2017-02-01       Impact factor: 14.676

10.  Assessing the Clinical Impact of Risk Models for Opting Out of Treatment.

Authors:  Kathleen F Kerr; Marshall D Brown; Tracey L Marsh; Holly Janes
Journal:  Med Decis Making       Date:  2019-01-16       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.